Cargando…
VHL and Hypoxia Signaling: Beyond HIF in Cancer
Von Hippel-Lindau (VHL) is an important tumor suppressor that is lost in the majority of clear cell carcinoma of renal cancer (ccRCC). Its regulatory pathway involves the activity of E3 ligase, which targets hypoxia inducible factor α (including HIF1α and HIF2α) for proteasome degradation. In recent...
Autores principales: | Zhang, Jing, Zhang, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874692/ https://www.ncbi.nlm.nih.gov/pubmed/29562667 http://dx.doi.org/10.3390/biomedicines6010035 |
Ejemplares similares
-
Playing Tag with HIF: The VHL Story
por: Leung, Sherri K., et al.
Publicado: (2002) -
The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
por: Peng, Song, et al.
Publicado: (2020) -
VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions
por: Mathó, Cecilia, et al.
Publicado: (2022) -
Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL
por: Li, Mingqing, et al.
Publicado: (2011) -
Investigation of the role of VHL-HIF signaling in DNA repair and apoptosis in zebrafish
por: Kim, Hyejeong Rosemary, et al.
Publicado: (2020)